PRODUCT LITERATURE

Azithromycin for acute lower respiratory tract infections (Review)

---

Acute lower respiratory tract infections (LRTI) range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia.
Approximately five million people die from acute respiratory tract infections annually. Among these, pneumonia represents the most
frequent cause of mortality, hospitalisation and medical consultation. Azithromycin is a macrolide antibiotic, structurally modified from
erythromycin and noted for its activity against some gram-negative organisms associated with respiratory tract infections, particularly
Haemophilus influenzae (H. influenzae)

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Azithromycin

Specific Detail Info

Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD001954.

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment